Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 16 2019 - 4:05PM
Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today
announced that on December 3, 2019, the Compensation Committee of
the Company’s Board of Directors approved equity award grants under
the Sientra, Inc. Inducement Plan to 15 new employees.
The new employees were granted restricted stock
units representing a total of 93,221 shares of common stock. The
restricted stock units will vest in three equal annual installments
following each individual employee’s hiring date. In each case, the
vesting of shares is contingent upon the individual’s continued
employment with the Company through each vesting date.
The grants were made as an inducement that was a
material component of each person’s compensation and subsequent
acceptance of employment with the Company or joining Sientra’s
subsidiary, miraDry, Inc., and were granted as an employment
inducement award pursuant to NASDAQ Listing Rule 5635(c)(4)
approved by the Compensation Committee.
About Sientra
Headquartered in Santa Barbara, California,
Sientra is a diversified global medical aesthetics company and a
leading partner to aesthetic physicians. The Company offers a suite
of products designed to make a difference in patients' lives by
enhancing their body image, growing their self-esteem, and
restoring their confidence. Sientra has developed a broad portfolio
of products with technologically differentiated characteristics,
supported by independent laboratory testing and strong clinical
trial outcomes. The Company’s Breast Products Segment
includes its OPUS™ breast implants, the first fifth generation
breast implants approved by the FDA for sale in the United States,
its ground-breaking Allox2® breast tissue expander with patented
dual-port and integral drain technology, and BIOCORNEUM® the
#1 performing, preferred and recommended scar gel of plastic
surgeons(*). The Company’s miraDry Segment comprises its
miraDry® system, which is approved for sale in over 40
international markets, and is the only non-invasive FDA-cleared
device for the permanent reduction of underarm sweat, odor and hair
of all colors.(*) Data on file
Investor Relations
805-679-8885
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Apr 2023 to Apr 2024